← Back to all trials
Recruiting
NCT05657769
Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung
Conditions: Diabetes Mellitus, Type 2
Sex: All
Ages: 18 Years – 60 Years
Phase: NA
Enrollment: 160
Sponsor: PT Bio Farma
Location: Indonesia
Summary
Randomized, unblinded, controlled, two arms parallel group, prospective intervention study
Eligibility Criteria
Inclusion Criteria:Subjects are in the diabetes type 2 status (based on Perkeni standard) HbA1c is ≥6.5%Aged 18 - 60 years oldHave compatible smartphone (minimum android 8 or iOS 13) and internet connectionReceiving regular diabetes treatmentGiving consent and commitment to participate in the study until finishLocated in Bandung Area within the treatment period (up to 3 month after receiving the treatment)Subject is determined to be able to complete daily physical activities.Exclusion Criteria:Pregnant (based on test pack)Participation in other weight loss programUse of other tracking applicationHaving any abnormalities that affecting blood erythrocyte age defined by laboratory examinationHave other severe diabetic complications that prevent subjects from participating in the prescribed program (Such as stroke, cardiac diseases (CHF stage III-IV), COPD or asthma with acute exacerbation and other respiratory diseases, peripheral artery disease, CKD stage 3-5) and other severe diseases that by the investigator's judgment, could not participate in this study
Source: ClinicalTrials.gov (NCT05657769). StuddyBuddy aggregates publicly available trial information.